Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Memphasys Ltd ( (AU:MEM) ).
Memphasys Limited has announced a change in the venue for its upcoming General Meeting, scheduled for 8 August 2025. The meeting will now be held at Level 32/200 George Street, and shareholders can participate by lodging proxy forms or attending in person. This change does not affect any other details previously released about the meeting.
More about Memphasys Ltd
Memphasys Limited (ASX: MEM) is a biotechnology company that focuses on advanced reproductive biotechnology. It develops medical devices, diagnostics, and proprietary media for both human and animal applications. The company is known for its flagship technologies, the Felix ™ and RoXsta ™ Systems, which aim to enhance fertility outcomes globally.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$9.92M
See more data about MEM stock on TipRanks’ Stock Analysis page.